Brief: Cue Health Makes De Novo Submission To FDA
01/09/2022 14:17
Sept 1 (Reuters) - Cue Health Inc HLTH.O :
* CUE HEALTH MAKES DE NOVO SUBMISSION TO FDA FOR FULL
CLEARANCE OF
ITS CUE® FLU MOLECULAR TEST
Source text for Eikon: ID:nPn2nhHra
Further company coverage: HLTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022